Lunai Bioworks, Inc. LNAI 深 沪
已收盘 08-07 16:00:00 美东时间
2.41
-0.010
-0.41%
华盛通- 最 高2.55
- 今 开2.40
- 成交量 3.77万股
- 最 低 2.39
- 昨 收 2.42
- 总市值 1092.67万
- 52周最高 5.02
- 市盈率 静 --
- 换手率 0.83%
- 52周最低 0.1214
- 委 比 -90.35%
- 总股本 453.39万
- 历史最高 13.78
- 量 比 0.02
- 振 幅 6.61%
- 历史最低 0.1214
- 每 手 1
- 风险率 0.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
Amended Complaint Alleges 29.6 Million Failed to Deliver Shares and Single Day Trading Volume of 15.3 Times Shares Outstanding, Company Seeks Treble Damages Under Federal RICO Statute WILMIN...
08-04 21:20
9 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $9.7 million. Greenland Mines (NASDAQ:GRML) stock moved upwards by 7.18% to $0.24. The company's market cap stands at $34.7 million. Lunai...
06-25 05:05
Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session
Lunai Bioworks Inc. (NASDAQ:LNAI) shares are trending on Wednesday. LNAI shares soared 80.88% to $5.15 after the bell on Tuesday, after the AI-powered biotechnology and biodefense company disclosed via a Securities and Exchange Commission filing that Nasdaq confirmed it had regained compliance with ...
06-17 12:05
Lunai Bioworks' BioSymetrics And BrainStorm Therapeutics Announce Strategic Collaboration And LOI Integrating AI Discovery, Human Brain Organoid Modeling, And In Vivo Validation To Generate Differentiated Neurology Assets For Pharmaceutical Partnering And Development
Lunai Bioworks' (NASDAQ:LNAI) wholly owned subsidiary BioSymetrics and BrainStorm Therapeutics today announced a strategic collaboration and Letter of Intent (LOI) to jointly discover, validate, and advance novel
05-28 21:21
Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K
Lunai Bioworks Inc. - Common Stock (NASDAQ:LNAI) reported quarterly losses of $(0.10) per share. The company reported $20.942 thousand in sales this quarter.
05-16 06:19
Lunai Bioworks Approves Reverse Stock Split At Ratio Of 1-For-3 To 1-For-30
Lunai Bioworks Inc. General Corporate Statement (Form8)Webmaster, Benzinga Editor UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to
05-14 04:53
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cellectar Biosciences (NASDAQ:CLRB) stock moved upwards by 45.0% to $4...
05-05 20:06
Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, valuing GME at $55.5B. eBay shares jumped 8.1% to $112.50 in pre-market trading.
05-04 16:57
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
Stock Market Today: Dow Jones, S&P 500 Futures Edge Lower Amid Extension Of Israel-Lebanon Ceasefire—Intel, SAP, Lunai Bioworks In Focus
U.S. stock futures were mixed on Friday following Thursday's decline, after President Donald Trump announced the extension of the ceasefire between Israel and Lebanon by three weeks. On Thursday, the Dow Jones index closed 179 points lower as investors gauged the evolving Middle East conflict and a downturn in the software sector.
04-24 17:31
